Akt inhibitor VIII was also used to treat the colon cancer cells in combination with 5-FU, and obviously increased the sensitivity of 5-FU therapy (Figure S3A), which further demonstrated the importance of Akt activation in resistance. The gene discussed is AKT1; the disease is malignant colon neoplasm.